CompaniesByCap
RXRX
Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare

Recursion Pharmaceuticals, Inc. Cash Flow 2019–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Operating Cash Flow-371.8M-359.2M-287.8M-83.5M-158.6M-45.4M-57.0M
Depreciation & Amort.83.7M36.5M24.4M11.8M8.4M3.9M2.5M
Investing Activities
Capital Expenditure6.5M13.7M12.0M37.1M39.8M5.8M3.9M
Free Cash Flow-378.3M-372.9M-299.7M-120.6M-198.4M-51.2M-61.0M
Financing Activities
Dividends Paid
Stock Buybacks

Recursion Pharmaceuticals, Inc. Cash Flow — FAQ

Recursion Pharmaceuticals, Inc. (RXRX) cash flow over the last 7 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RXRX's cash flow history?

The chart and table above show Recursion Pharmaceuticals, Inc.'s cash flow by year and by quarter, including the growth rate.